DrugPatentWatch Database Preview
Watson Pharms Teva Company Profile
» See Plans and Pricing
What is the competitive landscape for WATSON PHARMS TEVA, and what generic and branded alternatives to WATSON PHARMS TEVA drugs are available?
WATSON PHARMS TEVA has nine approved drugs.
Summary for Watson Pharms Teva
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 9 |
Drugs and US Patents for Watson Pharms Teva
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Pharms Teva | NORETHINDRONE AND ETHINYL ESTRADIOL | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 070685-001 | Jan 29, 1987 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072418-001 | Aug 1, 1989 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Pharms Teva | NORETHIN 1/35E-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 071480-001 | Apr 12, 1988 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Pharms Teva | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 206736-001 | Jan 19, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072421-001 | May 11, 1989 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
